Exact Mass: 353.9865

Exact Mass Matches: 353.9865

Found 95 metabolites which its exact mass value is equals to given mass value 353.9865, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pipobroman

3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one

C10H16Br2N2O2 (353.9578)


Pipobroman is only found in individuals that have used or taken this drug. It is an antineoplastic agent that acts by alkylation. [PubChem]The mechanism of action is uncertain but pipobroman is thought to alkylate DNA leading to disruption of DNA synthesis and eventual cell death. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents

   

idoxuridine

idoxuridine

C9H11IN2O5 (353.9713)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AD - Antivirals D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent Idoxuridine (5-Iodo-2′-deoxyuridine, 5-IUdR, IdUrd) is an iodinated thymidine analogue that competitively inhibits phosphorylases. Idoxuridine can inhibit viral activity, particularly viral eye infections, including herpes simplex keratitis, by inhibiting DNA polymerase and affecting viral replication. Idoxuridine against feline herpesvirus has the IC50 value of 4.3 μM[1]. Idoxuridine shows anti-orthopoxvirus activity.

   

Idoxuridine

1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


Idoxuridine is only found in individuals that have used or taken this drug. It is an analog of deoxyuridine that inhibits viral DNA synthesis. The drug is used as an antiviral agent. [PubChem]Idoxuridine acts as an antiviral agent by inhibiting viral replication by substituting itself for thymidine in viral DNA. This in turn inhibits thymidylate phosphorylase and viral DNA polymerases from properly functioning. The effect of Idoxuridine results in the inability of the virus to reproduce or to infect/destroy tissue. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AD - Antivirals D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent Idoxuridine (5-Iodo-2′-deoxyuridine, 5-IUdR, IdUrd) is an iodinated thymidine analogue that competitively inhibits phosphorylases. Idoxuridine can inhibit viral activity, particularly viral eye infections, including herpes simplex keratitis, by inhibiting DNA polymerase and affecting viral replication. Idoxuridine against feline herpesvirus has the IC50 value of 4.3 μM[1]. Idoxuridine shows anti-orthopoxvirus activity.

   

Dendrid

1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


   

5'-Iododeoxyuridine

1-{4-hydroxy-5-[hydroxy(iodo)methyl]oxolan-2-yl}-1,2,3,4-tetrahydropyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


   

Desacetylcephalothin

3-(Hydroxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C14H14N2O5S2 (354.0344)


   

Diphosphoglucuronic acid

2,3,4-trihydroxy-5-{[hydroxy(phosphonooxy)phosphoryl]oxy}-6-oxohexanoic acid

C6H12O13P2 (353.9753)


   

uric acid citrate

11-hydroxy-8,13,16-trioxa-1,5,7,14-tetraazatetracyclo[9.4.3.0^{3,7}.0^{4,14}]octadec-3-ene-2,6,9,12,15,17-hexone

C11H6N4O10 (354.0084)


   

(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid

(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid

C6H12O13P2 (353.9753)


   
   

4,4,4-Trifluoro-2-(isothioureido-thiophen-3-yl-methyl)-3-oxo-butyric acid ethyl ester

4,4,4-Trifluoro-2-(isothioureido-thiophen-3-yl-methyl)-3-oxo-butyric acid ethyl ester

C12H13F3N2O3S2 (354.032)


   
   

8-O-Methylthiomelin

8-O-Methylthiomelin

C16H12Cl2O5 (354.0062)


   

2,5-DICHLORO-1-HYDROXY-3,6-DIMETHOXY-8-METHYL-9H-XANTHEN-9-ONE

2,5-DICHLORO-1-HYDROXY-3,6-DIMETHOXY-8-METHYL-9H-XANTHEN-9-ONE

C16H12Cl2O5 (354.0062)


   

Demethylscensidin

Demethylscensidin

C16H12Cl2O5 (354.0062)


   

2,4-Dichloro-1-hydroxy-3,6-dimethoxy-8-methyl-9H-xanthen-9-one

2,4-Dichloro-1-hydroxy-3,6-dimethoxy-8-methyl-9H-xanthen-9-one

C16H12Cl2O5 (354.0062)


   

1,3-Dimethyl-2,4-dioxo-6-(methylsulfinyl)-1,2,3,4-tetrahydrothieno[3,2-g]pteridine-7-carboxylic acid

1,3-Dimethyl-2,4-dioxo-6-(methylsulfinyl)-1,2,3,4-tetrahydrothieno[3,2-g]pteridine-7-carboxylic acid

C12H10N4O5S2 (354.0093)


   
   

2,7-Dichlorolichexanthone

2,7-Dichlorolichexanthone

C16H12Cl2O5 (354.0062)


   

(?)-agelastatin E|8a-O-methylagelastatin A|agelastatin E

(?)-agelastatin E|8a-O-methylagelastatin A|agelastatin E

C13H15BrN4O3 (354.0327)


   

6-Bromogranulatimide

6-Bromogranulatimide

C15H7BrN4O2 (353.9752)


   

2,4-Dichlor-3,6-di-O-methylnorlichexanthone

"2,4-Dichlor-3,6-di-O-methylnorlichexanthone"

C16H12Cl2O5 (354.0062)


   

2,5-Dichlorolichexanthone

"2,5-Dichlorolichexanthone"

C16H12Cl2O5 (354.0062)


   

2,4-Dichlorolichexanthone

"2,4-Dichlorolichexanthone"

C16H12Cl2O5 (354.0062)


   

O-Desacetylcephalothin

O-Desacetylcephalothin

C14H14N2O5S2 (354.0344)


   
   

Nickel Diethyldithiocarbamate

Nickel Diethyldithiocarbamate

C10H20N2NiS4 (353.9863)


   

Methyl 8-bromo-4,5,6-trimethoxy-2-naphthoate

Methyl 8-bromo-4,5,6-trimethoxy-2-naphthoate

C15H15BrO5 (354.0103)


   

Methyl 7-bromo-5-hydroxy-4,8-dimethoxy-6-methyl-2-naphthoate

Methyl 7-bromo-5-hydroxy-4,8-dimethoxy-6-methyl-2-naphthoate

C15H15BrO5 (354.0103)


   

Tosufloxacin pharmaceutical intermediate

Tosufloxacin pharmaceutical intermediate

C15H6ClF3N2O3 (354.0019)


   

Carbamic acid, (2-chloro-3-iodo-4-pyridinyl)-, 1,1-dimethylethyl ester (9CI)

Carbamic acid, (2-chloro-3-iodo-4-pyridinyl)-, 1,1-dimethylethyl ester (9CI)

C10H12ClIN2O2 (353.9632)


   

n,n-ethylenebis(5-hydroxysalicylideneiminato)iron(ii)

n,n-ethylenebis(5-hydroxysalicylideneiminato)iron(ii)

C16H14FeN2O4 (354.0303)


   

2-{[(4-Bromophenyl)sulfonyl]amino}benzamide

2-{[(4-Bromophenyl)sulfonyl]amino}benzamide

C13H11BrN2O3S (353.9674)


   

calcium di(benzenesulphonate)

calcium di(benzenesulphonate)

C12H10CaO6S2 (353.9545)


   

2-(6-bromohexyl)-5-nitroisoindole-1,3-dione

2-(6-bromohexyl)-5-nitroisoindole-1,3-dione

C14H15BrN2O4 (354.0215)


   

6-bromo-2-naphthyl-beta-d-xylopyranoside

6-bromo-2-naphthyl-beta-d-xylopyranoside

C15H15BrO5 (354.0103)


   

Tungsten,tricarbonyl[(1,2,3,4,5,6-h)-1,3,5-cycloheptatriene]-

Tungsten,tricarbonyl[(1,2,3,4,5,6-h)-1,3,5-cycloheptatriene]-

C10H2O3W (353.9513)


   

4-Iodo-5-methoxy-N-phenylnicotinamide

4-Iodo-5-methoxy-N-phenylnicotinamide

C13H11IN2O2 (353.9865)


   

3,4-Dihydro-2-(3-methoxypropyl)-4-oxo-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide

3,4-Dihydro-2-(3-methoxypropyl)-4-oxo-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide

C10H14N2O6S3 (354.0014)


   

4,5-diamino-2-(4-bromo-2-chloroanilino)-3-fluorobenzonitrile

4,5-diamino-2-(4-bromo-2-chloroanilino)-3-fluorobenzonitrile

C13H9BrClFN4 (353.9683)


   

bis(trimethylstannyl)acetylene

bis(trimethylstannyl)acetylene

C8H18Sn2 (353.9452)


   

1-chloro-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexane

1-chloro-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexane

C6ClF13 (353.9481)


   

4-(4-IODO-PHENOXY)-BENZOIC ACID METHYL ESTER

4-(4-IODO-PHENOXY)-BENZOIC ACID METHYL ESTER

C14H11IO3 (353.9753)


   

3-(4-BROMO-2-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE

3-(4-BROMO-2-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE

C15H12BrClO3 (353.9658)


   

terbium acetate hydrate/

terbium acetate hydrate/

C6H11O7Tb (353.9758)


   

DIETHYL 4-IODOBENZYLPHOSPHONATE

DIETHYL 4-IODOBENZYLPHOSPHONATE

C11H16IO3P (353.9882)


   

5-Bromo-2-Chloro-N-[2-(Ethylamino)-3-Pyridinyl]-3-Pyridinecarboxamide

5-Bromo-2-Chloro-N-[2-(Ethylamino)-3-Pyridinyl]-3-Pyridinecarboxamide

C13H12BrClN4O (353.9883)


   

ethyl 3-(2,3-difluoro-5-iodophenyl)-3-oxopropanoate

ethyl 3-(2,3-difluoro-5-iodophenyl)-3-oxopropanoate

C11H9F2IO3 (353.9564)


   

5,5,6,6,7,7,8,8,9,9,9-undecafluorononane-2,4-dione

5,5,6,6,7,7,8,8,9,9,9-undecafluorononane-2,4-dione

C9H5F11O2 (354.0114)


   

Enisamium iodide

1-Methyl-4-[[(phenylmethyl)amino]carbonyl]pyridinium iodide

C14H15IN2O (354.0229)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Benzyl 2-hydroxy-5-iodobenzoate

Benzyl 2-hydroxy-5-iodobenzoate

C14H11IO3 (353.9753)


   

sulprofos sulfone

sulprofos sulfone

C12H19O4PS3 (354.0183)


   

tert-Butyl (6-chloro-4-iodopyridin-3-yl)carbamate

tert-Butyl (6-chloro-4-iodopyridin-3-yl)carbamate

C10H12ClIN2O2 (353.9632)


   

tert-butyl N-(2-chloro-4-iodopyridin-3-yl)carbamate

tert-butyl N-(2-chloro-4-iodopyridin-3-yl)carbamate

C10H12ClIN2O2 (353.9632)


   

1-(2-bromo-4,5-difluorobenzenesulfonyl)-4-methylpiperazine

1-(2-bromo-4,5-difluorobenzenesulfonyl)-4-methylpiperazine

C11H13BrF2N2O2S (353.9849)


   

2-iodotriphenylene

2-iodotriphenylene

C18H11I (353.9905)


   

Bis(acetylacetonato)barium n-hydrate

Bis(acetylacetonato)barium n-hydrate

C10H16BaO5 (354.005)


   

3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamide

3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamide

C8H14N6O4S3 (354.0239)


   
   

Terbium(Iii) Acetate Hydrate

Terbium(Iii) Acetate Hydrate

C6H11O7Tb (353.9758)


   

2,4,5-T BUTOXYETHYL ESTER

2,4,5-T BUTOXYETHYL ESTER

C14H17Cl3O4 (354.0192)


   

1,6-Divinylperfluorohexane

1,6-Divinylperfluorohexane

C10H6F12 (354.0278)


   

2-CHLORO-2-(TRIFLUOROMETHYL)PERFLUOROPENTANE

2-CHLORO-2-(TRIFLUOROMETHYL)PERFLUOROPENTANE

C6ClF13 (353.9481)


   

(3-Bromo-2-((2-chlorobenzyl)oxy)-5-methylphenyl)boronic acid

(3-Bromo-2-((2-chlorobenzyl)oxy)-5-methylphenyl)boronic acid

C14H13BBrClO3 (353.983)


   

(3-Bromo-2-((4-chlorobenzyl)oxy)-5-methylphenyl)boronic acid

(3-Bromo-2-((4-chlorobenzyl)oxy)-5-methylphenyl)boronic acid

C14H13BBrClO3 (353.983)


   

(3-Bromo-2-((3-chlorobenzyl)oxy)-5-methylphenyl)boronic acid

(3-Bromo-2-((3-chlorobenzyl)oxy)-5-methylphenyl)boronic acid

C14H13BBrClO3 (353.983)


   

3-(2-BROMO-4-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE

3-(2-BROMO-4-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE

C15H12BrClO3 (353.9658)


   

2,2,3,3,4,4,4-Heptafluorobutyl p-toluenesulfonate

2,2,3,3,4,4,4-Heptafluorobutyl p-toluenesulfonate

C11H9F7O3S (354.0161)


   

(4-BROMO-2,6-DICHLOROPHENOXY)(TERT-BUTYL)DIMETHYLSILANE

(4-BROMO-2,6-DICHLOROPHENOXY)(TERT-BUTYL)DIMETHYLSILANE

C12H17BrCl2OSi (353.9609)


   

5-Deoxy-5-iodouridine

5-Deoxy-5-iodouridine

C9H11IN2O5 (353.9713)


5'-Deoxy-5'-iodouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

Uridine, 2-deoxy-5-iodo-

1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

   

2-[(2,6-Dichlorophenyl)methylsulfanyl]-5-pyrazin-2-yl-1,3,4-thiadiazole

2-[(2,6-Dichlorophenyl)methylsulfanyl]-5-pyrazin-2-yl-1,3,4-thiadiazole

C13H8Cl2N4S2 (353.9567)


Yoda 1 is a potent and selective Piezo1 agonist. Yoda 1 activates purified Piezo1 channels. Yoda 1 potently inhibits macropinocytosis induced by epidermal growth factor (EGF). Yoda 1 enhances Ca2+ influx followed by activation of the calcium-activated potassium channel KCa3.1 and inhibition of Rac1 activation[1][2][3].

   

3-(3-bromo-4-hydroxy-5-methoxyphenyl)-2-cyano-N-(2-methoxyethyl)prop-2-enamide

3-(3-bromo-4-hydroxy-5-methoxyphenyl)-2-cyano-N-(2-methoxyethyl)prop-2-enamide

C14H15BrN2O4 (354.0215)


   

Silane, 1,3,5-benzenetriyltris[chlorodimethyl-

Silane, 1,3,5-benzenetriyltris[chlorodimethyl-

C12H21Cl3Si3 (354.0017)


   

2-[Carboxy-(2-thiophen-2-YL-acetylamino)-methyl]-5-methylene-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid

2-[Carboxy-(2-thiophen-2-YL-acetylamino)-methyl]-5-methylene-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid

C14H14N2O5S2 (354.0344)


   

Thymidine-5-(dithio)phosphate

Thymidine-5-(dithio)phosphate

C10H15N2O6PS2 (354.0109)


   

2,4-Dihydroxy-3-oxo-5-phosphonooxy-2-(phosphonooxymethyl)pentanoic acid

2,4-Dihydroxy-3-oxo-5-phosphonooxy-2-(phosphonooxymethyl)pentanoic acid

C6H12O13P2 (353.9753)


   

2,3,4-Trihydroxy-5-[hydroxy(phosphonooxy)phosphoryl]oxy-6-oxohexanoic acid

2,3,4-Trihydroxy-5-[hydroxy(phosphonooxy)phosphoryl]oxy-6-oxohexanoic acid

C6H12O13P2 (353.9753)


   

(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid

(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid

C6H12O13P2 (353.9753)


   

2-(2,4-dichlorophenoxy)-N-(4-methyl-2-nitrophenyl)acetamide

2-(2,4-dichlorophenoxy)-N-(4-methyl-2-nitrophenyl)acetamide

C15H12Cl2N2O4 (354.0174)


   

4-bromo-N-[(E)-quinoxalin-6-ylmethylidene]benzohydrazide

4-bromo-N-[(E)-quinoxalin-6-ylmethylidene]benzohydrazide

C16H11BrN4O (354.0116)


   

4-(4-bromophenyl)-2-(3-indolylidene)-3H-thiazole

4-(4-bromophenyl)-2-(3-indolylidene)-3H-thiazole

C17H11BrN2S (353.9826)


   

3-[[(2,4-Dichloroanilino)-sulfanylidenemethyl]amino]-4-methylbenzoic acid

3-[[(2,4-Dichloroanilino)-sulfanylidenemethyl]amino]-4-methylbenzoic acid

C15H12Cl2N2O2S (353.9997)


   

2-[(E)-2-(3-bromophenyl)ethenyl]-8-nitroquinoline

2-[(E)-2-(3-bromophenyl)ethenyl]-8-nitroquinoline

C17H11BrN2O2 (354.0004)


   

5-bromo-N-[(E)-(5-nitrothiophen-2-yl)methylidene]pyridine-3-carbohydrazide

5-bromo-N-[(E)-(5-nitrothiophen-2-yl)methylidene]pyridine-3-carbohydrazide

C11H7BrN4O3S (353.9422)


   

(1R,5S)-3-[2-chloro-4-(methylsulfonyl)benzoyl]-4-hydroxybicyclo[3.2.1]oct-3-en-2-one

(1R,5S)-3-[2-chloro-4-(methylsulfonyl)benzoyl]-4-hydroxybicyclo[3.2.1]oct-3-en-2-one

C16H15ClO5S (354.0329)


   

3-[2-Chloro-4-(methylsulfonyl)benzoyl]-4-hydroxybicyclo[3.2.1]oct-3-en-2-one

3-[2-Chloro-4-(methylsulfonyl)benzoyl]-4-hydroxybicyclo[3.2.1]oct-3-en-2-one

C16H15ClO5S (354.0329)


   

2-(heptafluoropropyl)-6-(trifluoromethyl)-1H-benzimidazole

2-(heptafluoropropyl)-6-(trifluoromethyl)-1H-benzimidazole

C11H4F10N2 (354.0215)


   

pipobroman

pipobroman

C10H16Br2N2O2 (353.9578)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents

   

1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione

1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


   

2,4-dichlorolichexanthone

2,4-dichlorolichexanthone

C16H12Cl2O5 (354.0062)


A member of the class of xanthones that is 9H-xanthen-9-one substituted by a hydroxy group at positions 1, chloro groups at positions 2 and 4, methoxy groups at positions 3 and 6 and a methyl group at position 8.

   

5-BDBD

5-BDBD

C17H11BrN2O2 (354.0004)


5-BDBD, a potent and selective P2X4 receptor antagonist, inhibits rP2X4R-mediated currents, with an IC50 of 0.75 μM. 5-BDBD completely blocks the basal and acute hyperalgesia induced by nitroglycerin (NTG)[1][2].

   

3-bromo-12-hydroxy-14-methoxy-13-methyl-2,8,11,13-tetraazatetracyclo[7.6.0.0²,⁶.0¹⁰,¹⁴]pentadeca-3,5,11-trien-7-one

3-bromo-12-hydroxy-14-methoxy-13-methyl-2,8,11,13-tetraazatetracyclo[7.6.0.0²,⁶.0¹⁰,¹⁴]pentadeca-3,5,11-trien-7-one

C13H15BrN4O3 (354.0327)


   

16-bromo-10-hydroxy-3,5,9,19-tetraazapentacyclo[10.7.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]nonadeca-1(12),2(6),4,7(11),9,13(18),14,16-octaen-8-one

16-bromo-10-hydroxy-3,5,9,19-tetraazapentacyclo[10.7.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]nonadeca-1(12),2(6),4,7(11),9,13(18),14,16-octaen-8-one

C15H7BrN4O2 (353.9752)


   

(1r,9r,10s,14s)-3-bromo-12-hydroxy-14-methoxy-13-methyl-2,8,11,13-tetraazatetracyclo[7.6.0.0²,⁶.0¹⁰,¹⁴]pentadeca-3,5,11-trien-7-one

(1r,9r,10s,14s)-3-bromo-12-hydroxy-14-methoxy-13-methyl-2,8,11,13-tetraazatetracyclo[7.6.0.0²,⁶.0¹⁰,¹⁴]pentadeca-3,5,11-trien-7-one

C13H15BrN4O3 (354.0327)